Systemic multi-target effects

Systemic multi-target effects refers to a pharmacological phenomenon where a therapeutic agent interacts with multiple distinct biological targets throughout the body rather than a single specific receptor or enzyme. This concept is central to polypharmacology, where the clinical efficacy or toxicity of a drug arises from the sum of its interactions across various pathways (Hopkins, 2008, Nature Chemical Biology). While multi-target drugs can be highly effective for complex diseases like cancer or psychiatric disorders, they often present challenges in drug design and safety due to the increased risk of off-target effects (Knight et al., 2010, Nature Reviews Cancer). This term does not represent a specific molecular target but rather describes a broad mechanism of drug action or a systemic physiological response (Peters, 2013, Dictionary of Pharmacological Terms). In clinical practice, systemic multi-target effects are often observed with drugs like multi-kinase inhibitors or broad-spectrum antipsychotics, which modulate entire biological networks (Anighoro et al., 2014, Journal of Medicinal Chemistry). Because it is a descriptive term for a drug's profile, it lacks a specific gene symbol, molecular classification, or localized biological function. Understanding these effects is crucial for biotech analysts evaluating the safety-to-efficacy ratio of complex therapeutic interventions.

Other names

PolypharmacologyMulti-target drug actionNetwork pharmacologyNon-specific systemic effects

Not applicable; this term describes a pharmacological profile involving multiple targets rather than a single molecular mechanism.